SÇSerpil Yanık Çolak

Serpil Yanık Çolak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Serpil Yanık Çolak has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Relationship Between Serum MG53 Levels and the Presence of Metabolic Syndrome and Its Components

    by Serpil Yanık Çolak, Burak Andaç, Eray Özgün, Buket Yılmaz Bülbül, Mine Okur, Ali Cem Yekdeş, Çağla Yıldız, Mehmet Çelik

    Background and Objectives: MG53 is a myokine/cardiokine involved in membrane repair. Some preclinical studies suggest that it is associated with insulin resistance. Metabolic syndrome (MS) is manifested by dyslipidemia, hypertension (HT), visceral obesity, hyperinsulinism, and glucose intolerance. We aimed to evaluate the relationship between the MG53 protein and MS and its components. Materials and Methods: This study was conducted among 64 patients with MS and 64 age- and sex-matched healthy participants. MG53 levels were measured using Human-MG53, a commercially available enzyme-linked immunosorbent assay (ELISA) kit (Cat# CSB-EL024511HU, Alfagen laboratory supplies, Cusabio, Bornova, İzmir.). Results: There was no significant connection between serum MG53 levels and the presence of MS (p = 0.969). We found no correlation between serum MG53 levels and the presence of HT, weight, waist circumference, body mass index, HDL-C, fasting blood glucose, and HbA1c levels. Conclusions: This study’s results suggest no association between serum MG53 levels and MS parameters in the studied ethnic population. Due to the limited number and controversy of available studies on this subject, our findings may provide perspective for conducting studies with more diverse populations to obtain more comprehensive results.


  • Retrospective Analysis of Factors Impairing Glycemic Control in Type 2 Diabetics on Intensive Insulin Therapy with HbA1c Levels of 10% or Above (Single-Center Experience)

    by Serpil Yanık Çolak, Yüksel Altuntaş

    Objectives: In this study, we aimed to investigate the effects of factors related to lifestyle, treatment compliance, and eating habits on blood glucose regulation in patients diagnosed with Type 2 DM (Diabetes Mellitus) with HbA1c 10% and above who are receiving intensive insulin therapy. Methods: The study sample consisted of 100 diabetic patients with inadequate glycemic control who applied to our clinic between January 2015 and December 2016. A questionnaire developed by the researchers was used in the study. The patients' sociodemographic and anthropometric characteristics, eating habits, compliance with insulin treatment, physical activity, and dental health data were documented. Results: Of the patients included in our study, 75% were female and 25% were male, the average age was 60, the average HbA1c was 12.3%, and the average Body Mass Index was 31.7 kg/m2. While 88% of our patients stated that they had three main meals a day, 12% stated that they skipped at least one main meal, and 64% had irregular eating habits. Forty percent of our patients skipped insulin doses at least 1-2 times a week, and there was a statistically significant relationship between the frequency of insulin dose skipping and HbA1c subgroups (p=0.014). Sixty-seven percent of our patients did not exercise daily. Conclusion: Although education level, eating habits, exercise, and dental health are among the variables affecting glycemic control in diabetic patients, the most critical factor affecting glycemic control in our study group was a lack of compliance with insulin injection.

  • Falsely Elevated Thyroid Stimulating Hormone in Two Cases Requiring Special Follow-up

    by Serpil Yanik Çolak, Eray Özgün, Burak Andaç, Mine Okur, Buket Yilmaz Bülbül, Mehmet Çeli̇k

  • Open Access

    25-Hydroxyvitamin D Status In Type 1 Diabetic Adults And Its Relationship With Glycemic Control

    by Burak Andaç, Buket Yılmaz Bülbül, Mehmet Oğulcan Tezel, Mine Okur, Serpil Yanık Çolak, Buse Ekici, Mehmet Celik

    Objective: To assess the vitamin D levels between adults with type 1 diabetes mellitus and the healthy control group and evaluate the relationship between HbA1c levels and vitamin D status in the diabetic group. Methods: Our cross-sectional, descriptive study included 98 type 1 diabetic patients over 18 years old who applied to the Endocrinology Outpatient Clinic and 95 age- and sex-matched individuals without chronic disease. Patients with advanced renal or liver disorders, primary hyperparathyroidism, metabolic bone disorders, or using medications that might change vitamin D concentrations were excluded from the study. HbA1c and 25(OH) Vitamin-D3 levels were measured three times in 9 months, and the average of the measurements was used. Diabetic patients and control individuals were separated into three groups according to their vitamin D levels as follows: deficiency ( 20 ng/ml). Results: Serum 25 (OH) vitamin D levels of diabetic patients were significantly lower than in healthy individuals (p=0.024). However, when diabetic adults were separated into three groups according to 25(OH) vitamin D levels, there was no significant difference regarding HbA1c levels (p=0.905). Conclusion: Although preclinical data support the role of low serum vitamin D levels in the etiopathogenesis of type 1 diabetes mellitus, studies examining the connection between low serum vitamin D levels and the prevalence of type 1 diabetes or glycemic control are not sufficient to reach a clear conclusion, including our study.